<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00489112</url>
  </required_header>
  <id_info>
    <org_study_id>0044-07-EMC</org_study_id>
    <nct_id>NCT00489112</nct_id>
  </id_info>
  <brief_title>The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will performe a prospective randomized study to evaluate the effects of the addition of
      alfuzocine xl 10 mg once a day for the conservative treatment of selected ureteral stones. A
      total of 60 patients with distal ureteral calculi will randomly divide into two treatment
      groups: group A (n=30) who will receive only analgetic therapy(Dipyrone)and diclofenac i.m.
      75mg and group B (n=30) who will receive the same therapy plus alfuzocin xl (10 mg/daily) for
      a maximum of 2 weeks.No significant differences will be between the groups for age, gender
      distribution and mean stone size measured in the single largest dimension at
      presentation.Randomization will be done only with the patients permission after they had read
      a summary describing the goals of conservative management and a description of the drugs they
      would be taking. Potential side effects and complications of the drugs were discussed. The
      expulsion rate will the primary end-point of this study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Distal Ureterolithiasis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alfuzocine XL 10 mg once a day</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stone in the distal ureter until 1 cm of diameter

        Exclusion Criteria:

          -  Evidence of urinary tract infection or sepsis

          -  Moderate or severe hydronephrosis

          -  Acute renal failure

          -  Ureteral stricture

          -  Stone with &gt;1cm of diameter

          -  Previuos use of alpha blocker

          -  Pregnancy

          -  Previuos ureteral endoscopic or open surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>doron perez, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>HaEmek MC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DORON PEREZ, M.D.</last_name>
    <phone>+972-4-6495115</phone>
    <email>perez_do@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Haemek medical center,urology department</name>
      <address>
        <city>Afula</city>
        <zip>18100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>doron perez, M.D.</last_name>
      <phone>+972-4-6495115</phone>
      <email>perez_do@clalit.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haemek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>doron perez, MD</last_name>
      <phone>+972-4-6495115</phone>
      <email>perez_do@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>doron perez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2007</study_first_submitted>
  <study_first_submitted_qc>June 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2007</study_first_posted>
  <last_update_submitted>June 25, 2007</last_update_submitted>
  <last_update_submitted_qc>June 25, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Ureteral Calculi</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

